Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Aclaris Therapts (ACRS)

Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 89,366
  • Shares Outstanding, K 70,925
  • Annual Sales, $ 31,250 K
  • Annual Income, $ -88,480 K
  • 60-Month Beta 0.21
  • Price/Sales 2.68
  • Price/Cash Flow N/A
  • Price/Book 0.52
Trade ACRS with:

Options Overview Details

View History
  • Implied Volatility 85.91% ( -8.61%)
  • Historical Volatility 66.75%
  • IV Percentile 41%
  • IV Rank 12.31%
  • IV High 494.95% on 10/26/23
  • IV Low 28.49% on 04/06/23
  • Put/Call Vol Ratio 0.86
  • Today's Volume 52
  • Volume Avg (30-Day) 115
  • Put/Call OI Ratio 0.22
  • Today's Open Interest 4,551
  • Open Int (30-Day) 4,203

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.28
  • Number of Estimates 5
  • High Estimate -0.08
  • Low Estimate -0.35
  • Prior Year -0.42
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1100 +12.61%
on 03/15/24
1.5100 -17.22%
on 03/06/24
+0.0600 (+5.04%)
since 02/28/24
3-Month
0.8555 +46.11%
on 01/12/24
1.5100 -17.22%
on 03/06/24
+0.1800 (+16.82%)
since 12/28/23
52-Week
0.5902 +111.79%
on 11/13/23
11.1200 -88.76%
on 07/17/23
-6.7900 (-84.45%)
since 03/28/23

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Aclaris Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing drugs to met needs in dermatology. Its drug candidate consists of A-101, a high-concentration hydrogen peroxide topical solution which is being developed as a prescription...

See More

Key Turning Points

3rd Resistance Point 1.3950
2nd Resistance Point 1.3400
1st Resistance Point 1.3000
Last Price 1.2400
1st Support Level 1.2050
2nd Support Level 1.1500
3rd Support Level 1.1100

See More

52-Week High 11.1200
Fibonacci 61.8% 7.0976
Fibonacci 50% 5.8551
Fibonacci 38.2% 4.6126
Last Price 1.2400
52-Week Low 0.5902

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar